• NARCAN® Nasal Spray approved by the FDA
  • Changed name from Lightlake Therapeutics to Opiant Pharmaceuticals
  • Licensed heroin vaccine from Walter Reed for Opioid Use Disorder
  • Initiated OPNT001 Phase 2 study in Bulimia Nervosa
  • Uplisted to NASDAQ